DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cimetropium bromide
Cimetropium bromide
Muscarinic Acetylcholine Receptor
The Role of Antispasmodics in Managing Irritable Bowel Syndrome
Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition
IBS Treatment
Pharmaceutical Appendix to the Harmonized Tariff Schedule
(12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Current Pharmacologic Treatments of Irritable Bowel Syndrome
Controlled Clinical Trial
Pharmacokinetics
Methylnaltrexone Bromide
Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)
Meta-Analysis: the Treatment of Irritable Bowel Syndrome
Product Overview
Comparison Between the Effectiveness of Oral Phloroglucin
Pharmaceuticals Appendix
1720 Gastrointestinal Drugs 3
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Top View
Product List
Solutions to Pharmaceutical Issues for Anti-Cancer Drugs by Accord Excel
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Atc Index 2010
Irritable Bowel Syndrome. Relevance of Antispasmodics
Customs Tariff - Schedule
Customs Tariff - Schedule Xxi - 1
(12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
Oil in the Treatment of Irritable Bowel Effect of Fibre, Antispasmodics, And
IBS-Monograph-2018.Pdf
Medications, Dry Mouth and Dental Caries Among Older People: a Longitudinal Study
Pharmaceutical Appendix to the Tariff Schedule 2
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Review Treatment of Irritable Bowel Syndrome
ICD-10-CM TABLE of DRUGS and CHEMICALS
Pharmaceutical Appendix to the Tariff Schedule 2
A European Approach to Irritable Bowel Syndrome Management
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Focus on Otilonium Bromide
ICD-10-CM Table of Drugs 2019
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Irritable Bowel Syndrome (IBS)
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Effect of Fibre, Antispasmodics, and Peppermint Oil in the Treatment of Irritable Bowel Syndrome: Systematic Review and Meta-Analysis